EBI-005: Clinical Trials

1 trial of EBI-005, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow EBI-005: new trials by email Literature Review of EBI-005 trials Research Report on EBI-005

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Isunakinra Alone and in Combination With a PD-1/PD-L1 Inhibitor in Patients With Solid Tumors
Isunakinra, PD-(L)1 Inhibitor - Solid Tumor, Adult
Phase 1 / Phase 2CompletedBuzzard Pharmaceuticals152020-09-012024-08-06

Sponsors

Buzzard Pharmaceuticals (1)

Countries

United States (1)

Top investigators

Maarten de Chateau, MD, PhD (1)